New horizons in the treatment of tuberculosis
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 54 (11) , 1165-1172
- https://doi.org/10.1016/s0006-2952(97)00163-9
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- The action of antituberculosis drugs in short-course chemotherapyPublished by Elsevier ,2004
- Evidence for Isoniazid Oxidation by Oxyferrous Mycobacterial Catalase−PeroxidaseJournal of the American Chemical Society, 1996
- An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and an altered oxidative‐stress responseMolecular Microbiology, 1996
- The Biosynthesis of Cyclopropanated Mycolic Acids in Mycobacterium tuberculosisPublished by Elsevier ,1995
- Dormancy ofMycobacterium tuberculosis and latency of diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- MycDB: an integrated mycobacterial databaseMolecular Microbiology, 1994
- Synthesis and Biological Activity of 3'-Hydroxy-5'-aminobenzoxazinorifamycin Derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993
- Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimuriumCell, 1985
- Electron spin resonance-spin trapping. Detection of superoxide formation during aerobic microsomal reduction of nitro-compoundsBiochemical and Biophysical Research Communications, 1978
- Evaluation of the routes of glucose utilization in virulent and avirulent strains of Mycobacterium tuberculosisBiochimica et Biophysica Acta, 1962